Skip to main content

Table 1 Baseline patient demographics

From: A cluster-based analysis evaluating the impact of comorbidities in fibrotic interstitial lung disease

Characteristics

IPF

(n = 330)

CTD-ILD

(n = 672)

Fibrotic HP

(n = 135)

Unclassifiable

(n = 343)

Age, years

68 ± 8

57 ± 13

62 ± 12

65 ± 12

Male

246 (75%)

209 (31%)

59 (44%)

185 (54%)

BMI, kg/m2

29 ± 5

28 ± 6

31 ± 6

30 ± 6

Current or past smoking

263 (80%)

335 (50%)

73 (54%)

217 (63%)

 Smoking pack-years

21 (2–37)

0 (0–18)

4 (0–21)

8 (0–28)

Baseline lung function

    

 FVC, %-predicted

80 ± 18

77 ± 19

75 ± 19

81 ± 20

 DLCO, %-predicted

60 ± 18

63 ± 20

62 ± 19

65 ± 21

  1. Values represent mean ± standard deviation, number (percent), or median (interquartile range)
  2. BMI body mass index, FVC forced vital capacity, DLCO diffusing capacity of the lung for carbon monoxide, IPF idiopathic pulmonary fibrosis, CTD-ILD connective tissue disease-associated ILD, HP hypersensitivity pneumonitis